Table 3.
Differences in clinicopathological data and the presence of BRAF V600E mutation in the cohort of 44 cases of ameloblastoma
| Parameter | BRAF V600E | WT | P value |
|---|---|---|---|
| Gender | |||
| Male | 11 | 19 | >0.05a |
| Female | 8 | 6 | |
| Age | 47.1 ± 17.1 | 50.0 ± 20.5 | >0.05b |
| Site | |||
| Maxilla | 0 | 15 | <0.000 1a |
| Mandible | 19 | 10 | |
| Histotype | |||
| Conventional | 1 | 14 | |
| Unicystic | 15 | 3 | <0.000 1a |
| Peripheral | 3 | 8 | |
| Size (cm) | 3.7 ± 2.2 | 3.2 ± 1.5 | >0.05b |
| Clinical form | |||
| Primary | 13 | 13 | >0.05a |
| Recurrence | 6 | 12 | |
WT wild type, cm centimeters
aChi square test
bMann–Whitney U test
Bold values denote statistical significance at the P < 0.05